Dimensional Fund Advisors LP United Therapeutics Corp Transaction History

Dimensional Fund Advisors LP

  • $391 Billion
  • Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 624,711 shares of UTHR stock, worth $199 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
624,711
Previous 620,566 0.67%
Holding current value
$199 Million
Previous $219 Million 12.05%
% of portfolio
0.05%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$304.42 - $380.78 $1.26 Million - $1.58 Million
4,145 Added 0.67%
624,711 $193 Million
Q4 2024

Feb 13, 2025
SELL
$348.66 - $410.0 $162,475 - $191,060
-466 Reduced 0.08%
620,566 $219 Million
Q3 2024

Nov 07, 2024
BUY
$311.04 - $363.55 $10.9 Million - $12.7 Million
35,063 Added 5.98%
621,032 $223 Million
Q2 2024

Aug 09, 2024
BUY
$228.26 - $319.04 $5.18 Million - $7.24 Million
22,683 Added 4.03%
585,969 $187 Million
Q1 2024

May 10, 2024
BUY
$210.76 - $249.51 $281,575 - $333,345
1,336 Added 0.24%
563,286 $129 Million
Q4 2023

Feb 07, 2024
BUY
$214.88 - $256.94 $2.14 Million - $2.56 Million
9,962 Added 1.8%
561,950 $124 Million
Q3 2023

Nov 09, 2023
BUY
$211.82 - $248.24 $3.65 Million - $4.28 Million
17,234 Added 3.22%
551,988 $125 Million
Q2 2023

Aug 09, 2023
BUY
$205.19 - $232.99 $3.5 Million - $3.98 Million
17,077 Added 3.3%
534,754 $118 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $4.72 Million - $6.12 Million
22,169 Added 4.47%
517,677 $116 Million
Q4 2022

Feb 09, 2023
SELL
$205.95 - $280.43 $6.8 Million - $9.26 Million
-33,014 Reduced 6.25%
495,508 $138 Million
Q3 2022

Nov 10, 2022
BUY
$203.3 - $244.17 $848,574 - $1.02 Million
4,174 Added 0.8%
528,522 $111 Million
Q2 2022

Aug 12, 2022
SELL
$174.81 - $241.14 $6.58 Million - $9.07 Million
-37,618 Reduced 6.69%
524,348 $124 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $2.04 Million - $2.63 Million
-12,270 Reduced 2.14%
561,966 $101 Million
Q4 2021

Feb 09, 2022
SELL
$184.32 - $216.08 $4.87 Million - $5.71 Million
-26,423 Reduced 4.4%
574,236 $124 Million
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $10.2 Million - $12.2 Million
-56,936 Reduced 8.66%
600,659 $111 Million
Q2 2021

Aug 12, 2021
SELL
$170.47 - $211.93 $16.4 Million - $20.4 Million
-96,388 Reduced 12.78%
657,595 $118 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $20.4 Million - $23.1 Million
-132,351 Reduced 14.93%
753,983 $126 Million
Q4 2020

Feb 25, 2021
BUY
$101.87 - $151.79 $90.3 Million - $135 Million
886,334 New
886,334 $135 Million

Others Institutions Holding UTHR

# of Institutions
733
Shares Held
43.6M
Call Options Held
124K
Put Options Held
122K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email